$Eli Lilly(LLY.US) | BMO Capital ๐ซ๐๐ข๐ญ๐๐ซ๐๐ญ๐๐ฌ ๐๐ฎ๐ญ๐ฉ๐๐ซ๐๐จ๐ซ๐ฆ on ๐๐ฅ๐ข ๐๐ข๐ฅ๐ฅ๐ฒ, maintains ๐๐ ๐๐ญ $๐๐๐๐
Analyst sees early data for acquired JAK2i AJ1-11095 as highly competitive and potentially best-in-class, supporting Lilly's business development strategy.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments